New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 30, 2014
09:18 EDTTHS, MNKD, BK, YHOO, PPG, APP, RMD, DRNA, GWPH, MBIOn The Fly: Pre-market Movers
HIGHER: MannKind (MNKD), up 9.8% after company confirms FDA approval of Afrezza inhalation powder to improve glycemic control in adult patients with diabetes... Yahoo (YHOO), up 1.6% after being upgraded to Overweight at Piper Jaffray... BNY Mellon (BK), up 3.5% after Activist investor Trian Partners discloses 9.33M share stake... Dicerna Pharmaceuticals (DRNA), up 8.3% after announcing preclinical data demonstrating the promise of DCR-PH1... TreeHouse Foods (THS), up 5% after agreeing to acquire Flagstone Foods for $860M... PPG Industries (PPG), up 5.6% after agreeing to acquire privately-held Consorcio Comex, an architectural and industrial coatings company in Mexico, in transaction is valued at $2.3B... GW Pharmaceuticals (GWPH), up 4.8% after Piper Jaffray raises price target on its stock to $147 from $97. LOWER: American Apparel (APP), down 11% after adopting stockholder rights plan, rejecting Dov Charney request for special meeting... MBIA (MBI), down 4.3% after stock was downgraded to Neutral at BTIG... ResMed (RMD), down 3.8% following cautious mention of the stock in this weekend's Barron's magazine.
News For YHOO;MBI;RMD;BK;GWPH;APP;MNKD;DRNA;PPG;THS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
November 19, 2014
16:59 EDTYHOOYahoo, Mozilla form strategic partnership
Subscribe for More Information
15:53 EDTYHOOSome make case for Yahoo considering BlackBerry acquistion, Re/code says
Sources close to Yahoo (YHOO) said the company has been considering several "big acquisitions," largely aimed at helping its display business, and is eyeing tech-related companies including MediaMath, RadiumOne and Turn, reported Re/code's Kara Swisher. Swisher added that "one of the most far-out" ideas that has been "floated by bankers and other sundry pundits" is that Yahoo should buy BlackBerry (BBRY), and Swisher said that while that may seem unlikely, such a purchase would be "well within the amount" that Yahoo CEO Marissa Mayer has to spend. Reference Link
11:20 EDTYHOOStocks with call strike movement; FSLR YHOO
Subscribe for More Information
10:50 EDTYHOO, YHOOYahoo price target raised to $57 from $47 at CLSA
Subscribe for More Information
09:38 EDTYHOOCCS Insight predicts Netflix to be acquired next year, FT reports
CCS Insight, a U.K.-based technology research firm, is predicting that a major internet player such as Yahoo (YHOO), Alibaba (BABA) or Google (GOOG) will buy Netflix (NFLX) next year, reported Financial Times. Reference Link
07:37 EDTBKCitigroup to hold a conference
Global Financial Conference is being held in Singapore on November 19-20.
November 18, 2014
10:29 EDTYHOOOptions with increasing implied volatility: YHOO PSEC
Subscribe for More Information
08:25 EDTYHOOYahoo price target raised to $60 from $50 at Bernstein
Bernstein increased its price target on Yahoo (YHOO) after raising its estimate of Alibaba's valuation to $350B. Bernstein keeps a Market Perform rating on Yahoo.
November 17, 2014
16:00 EDTYHOOOptions Update; November 17, 2014
Subscribe for More Information
11:44 EDTYHOOStocks with call strike movement; YHOO NFX
Yahoo (YHOO) February 60 call option implied volatility increased 4% to 39, Newfield Exploration (NFX) March 38 call option implied volatility increased 9% to 40 according to IVolatility.
09:36 EDTYHOOActive equity options trading
Active equity options trading according to Track Data: AAPL PBR BHI GILD MU HD AMZN TSLA YHOO FB TWTR
08:19 EDTDRNADicerna expects to release initial Phase 1 data from DCR-PH1 trial by 2015-end
Dicerna expects to release initial data from a phase 1 clinical trial of DCR-PH1 in patients with PH1 by the end of 2015. In preclinical studies, DCR-PH1 induces potent and long-term inhibition of HAO1 and significantly reduces urinary oxalate levels, while demonstrating long-term tolerability in animal models of PH1. Following an extensive review of rare diseases with gene targets expressed in the liver, Dicerna has prioritized a broad portfolio of research and development opportunities. The company is currently pursuing discovery research on several rare diseases involving the liver and intends to add additional programs over time. Dicerna expects to declare its first DsiRNA-EX conjugate clinical candidate in 2015 for an undisclosed rare disease involving the liver. For competitive reasons, the company does not plan to specify disease areas or therapeutic targets until a program has reached a late preclinical stage.
08:12 EDTDRNADicerna announces license agreement with Tekmira for PH1 program
Dicerna Pharmaceuticals (DRNA) announced a licensing agreement for Dicerna to use Tekmira’s (TKMR) proprietary lipid nanoparticle technology for delivery of DCR-PH1, Dicerna’s investigational product candidate for primary hyperoxaluria type 1, a rare, inherited liver disorder that often results in kidney failure, and for which there are no approved therapies. This announcement follows the successful testing of DCR-PH1 in combination with Tekmira's LNP technology in animal models, including mice and non-human primates. Under the agreement, Dicerna will pay Tekmira $2.5 million upfront, as well as $22 million in potential development milestones, and a mid-single-digit royalty on future PH1 sales. Tekmira’s LNP system has shown in other human clinical studies to provide potent, safe and effective RNA delivery to hepatocytes. Licensing Tekmira’s LNP will streamline the development path for DCR-PH1 and allows Dicerna to focus its LNP efforts on its oncology pipeline.
06:16 EDTYHOOInvestors wanting Alibaba should consider Yahoo, says Citigroup
Subscribe for More Information
November 14, 2014
17:07 EDTYHOOSoros Fund Management gives quarterly update on stakes
Subscribe for More Information
16:39 EDTBKBerkshire Hathaway gives quarterly update on stakes
Subscribe for More Information
13:39 EDTAPPBigger Capital calls for American Apparel's board to be reconstituted
Bigger Capital Fund and the Bigger Family, collectively owning more than 2M shares of American Apparel announced that they have delivered a letter to American Apparel's board. In the letter, Bigger Capital said, We write to you to express our serious and growing concerns with the company and provide the basis for our conviction that the board must be immediately reconstituted to replace David Danzinger and Allan Mayer with direct representatives of American Apparel's minority shareholders... We renew our call for the resignations of Messrs. Danzinger and Mayer for a number of reasons... we are becoming increasingly concerned that the new Board, led by Co-Chairmen Danzinger and Mayer, is not as committed to protect the interests of all shareholders as we had hoped. For example, this Board never bothered to respond to our July 17th letter or address our concerns in any form. At a time when the Company is suffering ever widening losses, is embroiled in a much publicized investigation of its former CEO, is still absorbing changes in its senior executive team, and the stock is taking a beating, the Board has a heightened responsibility to soothe shareholder concerns and assure us that all is being done to protect our investment. Such disregard of minority shareholders especially at this critical time is inexcusable... As things currently stand, American Apparel is continuing to sustain massive losses and erosion of shareholder value persists. The Company has massively underperformed peers on a profitability basis for years... Our expectation is that the Board will immediately engage with us to work constructively towards a solution along the lines laid out in this letter."
13:03 EDTYHOOYahoo rises after analysts boost targets
Subscribe for More Information
08:25 EDTYHOOYahoo price target raised to $61 from $49 at Oppenheimer
Oppenheimer increased its price target on Yahoo (YHOO) as the firm raised its valuation of Alibaba (BABA) to $324B from $275B. The firm keeps an Outperform rating on Yahoo.
08:21 EDTYHOOYahoo price target raised to $60 from $50 at FBR Capital
FBR Capital raised its price target for Yahoo (YHOO) shares to $60 to reflect Alibaba (BABA) stock appreciation. FBR says Yahoo offers a lower-cost play on Alibaba with the potential for improved core Yahoo performance. It keeps an Outperform rating on the stock.
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use